High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia (HDL)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2015 by Northwestern University
Sponsor:
Collaborator:
Sunovion
Information provided by (Responsible Party):
Herbert Meltzer, Northwestern University
ClinicalTrials.gov Identifier:
NCT01569659
First received: March 29, 2012
Last updated: March 26, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)